Add to ORKGnn at3 Background A number of preclinical studies have demonstrated that Schem et al. BMC Cancer 2013, 13:3
Copyright © 2014 Pavan P. Adiseshaiah et al. This is an open access article distributed under the Cr...
Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency s...
iga he ul se ll l chemotherapy has improved the outcomes of DLBCL, many patients do not achieve comp...
en no R many cancers, with more than 60 % of new cancers and [12-18]. Very little data exist on the ...
nant disease of hematopoietic stem and progenitor cells molecular genetics have already facilitated ...
tumorogenesis, and is associated with a better outcome for breast cancer patient
nse to chemotherapy in and progressive disease (22.2%) had an increase of CEA levels of 9.4 % (95 % ...
which permits unrestricted noncommercial use, provided the original work is properly cited. Cancer M...
de de phological, clinical and molecular characteristics. s-BOTs lenging to identify patients at ris...
Non-synonymous variations in cancer and their effects on the human pro rare and novel SNVs that are ...
among human papillomav tt nin reducing the risk of CIN3 and cervical cancer and allows mal cytology ...
Although breast cancer is the second most leading cause 15-20 % of all breast cancers and the signat...
ka tio re cancer cases were diagnosed in 2010 [2]. However, can- tion of cancers being caused by maj...
om mp te predictor of survival for patients with colorectal cancer. follows: Gao et al. BMC Cancer 2...
plicated in a number of human cancers including breast velopment. The other transgenic model was dev...
Copyright © 2014 Pavan P. Adiseshaiah et al. This is an open access article distributed under the Cr...
Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency s...
iga he ul se ll l chemotherapy has improved the outcomes of DLBCL, many patients do not achieve comp...
en no R many cancers, with more than 60 % of new cancers and [12-18]. Very little data exist on the ...
nant disease of hematopoietic stem and progenitor cells molecular genetics have already facilitated ...
tumorogenesis, and is associated with a better outcome for breast cancer patient
nse to chemotherapy in and progressive disease (22.2%) had an increase of CEA levels of 9.4 % (95 % ...
which permits unrestricted noncommercial use, provided the original work is properly cited. Cancer M...
de de phological, clinical and molecular characteristics. s-BOTs lenging to identify patients at ris...
Non-synonymous variations in cancer and their effects on the human pro rare and novel SNVs that are ...
among human papillomav tt nin reducing the risk of CIN3 and cervical cancer and allows mal cytology ...
Although breast cancer is the second most leading cause 15-20 % of all breast cancers and the signat...
ka tio re cancer cases were diagnosed in 2010 [2]. However, can- tion of cancers being caused by maj...
om mp te predictor of survival for patients with colorectal cancer. follows: Gao et al. BMC Cancer 2...
plicated in a number of human cancers including breast velopment. The other transgenic model was dev...
Copyright © 2014 Pavan P. Adiseshaiah et al. This is an open access article distributed under the Cr...
Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency s...
iga he ul se ll l chemotherapy has improved the outcomes of DLBCL, many patients do not achieve comp...